Located in Boston and the surrounding communities, Dana-Farber Cancer Institute brings together world renowned clinicians, innovative researchers and dedicated professionals, allies in the common mission of conquering cancer, HIV/AIDS and related diseases. Combining extremely talented people with the best technologies in a genuinely positive environment, we provide compassionate and comprehensive care to patients of all ages; we conduct research that advances treatment; we educate tomorrow's physician/researchers; we reach out to underserved members of our community; and we work with amazing partners, including other Harvard Medical School-affiliated hospitals.
The Dana-Farber Cancer Institute (DFCI) is committed to providing outstanding departmental management to DFCI faculty engaged in research. The purpose of the Departmental Grants Management Specialist (DGMS) is to provide support to faculty preparing grant applications (Sponsored Research) and managing finances of the faculty portfolio after the award (Finance). Finance includes managing accounts associated with grants, gifts, strategic centers, and other types of funding. This position provides financial information, guidance, analysis and support to faculty. Sponsored Research includes reviewing sponsor eligibility and application requirements and being responsible for the entire award application excluding scientific content. Some positions are more heavily weighted on either Sponsored Research or Finance depending on the scope of the particular position and the needs of the department over time. In addition to the grant management responsibilities described, the position may include special projects either within the department or across departments, supervising junior staff, training, and mentoring.
This position is within the Department of Medical Oncology, Division of Hematologic Neoplasia. In the Hematologic Neoplasia Division, physician-scientists and staff primarily study blood cancers including leukemia, lymphoma and myeloma and the immune responses required to eradicate blood cancers and other types of tumors. HN faculty are both physician-scientists and basic researchers and are members of the Department of Medicine at Harvard Medical School. The Division includes 49 faculty, 27 research scientists, and 87 research fellows as part of 22 independent investigator-led laboratory groups. The division occupies 36,000 square feet of wet lab space with $40 million dollars of external grant funding. Portfolios include all external grant funding for 30 additional faculty members within the Disease Centers of Hematologic Malignancies. Overall funding from all sources for HN and HM totals $73 million.
Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other groups as protected by law.